![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Mandrekar Sumithra J.
Publisher: Adis International
ISSN: 1175-2203
Source: American Journal of PharmacoGenomics, Vol.5, Iss.5, 2005-01, pp. : 317-325
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Impact of biomarkers on clinical trial risk
By Reid Geoffrey Gilbert John Bin Yameen Tarek Abdullah Parker Jayson Lee
Pharmacogenomics, Vol. 14, Iss. 13, 2013-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Lockwood Peter Ewy Wayne Hermann David Holford Nick
Pharmaceutical Research, Vol. 23, Iss. 9, 2006-09 ,pp. :